Combo inhaler lacks evidence for first-line use in asthma: PBAC
The committee has revealed why it refused to fund budesonide-formoterol for mild asthma
3rd December 2019
Despite new international guidelines recommending combination budesonide-formoterol as first-line for mild asthma, the PBAC says there is a lack of evidence for such advice.